OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway
Aiqun Liu, Baohong Jiang, Cailu Song, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Circular RNA: A promising new star of vaccine
Jindong Xie, F. Ye, Xinpei Deng, et al.
Journal of Translational Internal Medicine (2023) Vol. 11, Iss. 4, pp. 372-381
Open Access | Times Cited: 40

Long non-coding RNAs and JAK/STAT signaling pathway regulation in colorectal cancer development
Abdolmajid Ghasemian, Hadeel A. Omear, Yaser Mansoori, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 39

CircRNA‐associated ceRNA regulatory networks as emerging mechanisms governing the development and biophysiopathology of epilepsy
Maryam Kohansal, Yasemin Khudiar Alghanimi, Shaimaa R. Banoon, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 4
Open Access | Times Cited: 15

circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis
Zhigang Zhou, Jing Qin, Cailu Song, et al.
Journal of Cancer (2023) Vol. 14, Iss. 13, pp. 2574-2584
Open Access | Times Cited: 36

CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression
JUNZHE YI, Binbin Li, Xiaomin Yin, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 6, pp. 1129-1139
Open Access | Times Cited: 9

Isocucurbitacin B Inhibits Gliomas Through the Promotion of Anoikis by Targeting Caveolin 1
Mingyu Han, Pingting Chen, Fu Peng, et al.
(2025)
Closed Access

miR-28–3p suppresses gastric cancer growth and EMT-driven metastasis by targeting the ARF6/Hedgehog axis
Ji Hua, Sicheng Liu, Libo Yang, et al.
Molecular and Cellular Probes (2025) Vol. 79, pp. 102010-102010
Open Access

Aurora-A promotes lenvatinib resistance experimentally through hsa-circ-0058046/miR-424-5p/FGFR1 axis in hepatocellular carcinoma
Mubalake Abudoureyimu, Ni Sun, Weiwei Chen, et al.
International Journal of Immunopathology and Pharmacology (2025) Vol. 39
Open Access

Circular RNA circLIFR suppresses papillary thyroid cancer progression by modulating the miR-429/TIMP2 axis
Fengyuan Zhang, Jiazheng Li, Jingjing Xu, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access | Times Cited: 3

circ_SMA4 promotes gastrointestinal stromal tumors malignant progression by sponging miR-494-3p/KIT axis and activating JAK/STAT pathway
Fangwen Zou, Yifang Tang, Xiaojing Li, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2

Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for glioma
Wenzhe An, Qingqing Yang, Yunlan Xi, et al.
Life Sciences (2023) Vol. 338, pp. 122392-122392
Closed Access | Times Cited: 7

Pathway‐based stratification of gliomas uncovers four subtypes with different TME characteristics and prognosis
Ruoyu Huang, Bo Han, Ying Zhang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 8
Open Access | Times Cited: 1

The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort
Qianrong Huang, Qian Jiang, Ju-Yuan Tan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

WTAP‐mediated m6A modification of circ_0032463 promotes osteosarcoma progression by sponging miR‐145‐5p and regulating GFRA1 expression
Zhong Huang, Pengcheng Chen, Yiheng Liu
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 9
Closed Access | Times Cited: 1

CircRNome‐wide characterisation reveals the promoting role of circAATF in anti‐PD‐L1 immunotherapy of gallbladder carcinoma
Yueqi Wang, Shengli Li, Xiaobo Bo, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 10
Open Access | Times Cited: 1

Hsa_circ_0080608 Attenuates Lung Cancer Progression by Functioning as a Competitive Endogenous RNA to Regulate the miR-661/ADRA1A Pathway
Chengbo Ren, Ling Cui, R.L. Li, et al.
Hormone and Metabolic Research (2023) Vol. 55, Iss. 12, pp. 876-884
Closed Access | Times Cited: 3

Bibliometric Analysis to Improve Combined Treatment Strategies for Glioblastoma in America
José Molina-García, David Vázquez, Ernesto Piñón, et al.
Current Cancer Therapy Reviews (2024) Vol. 20, Iss. 6, pp. 578-587
Closed Access

Knockdown of PGBD5 inhibits the malignant progression of glioma through upregulation of the PPAR pathway
Pengren Luo, Jinhong Yang, Li-peng Jian, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 5
Open Access

SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression
Chunyuan Luo, Juan He, Yang Yang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access

CircNUP98 promotes the malignant behavior of glioma cells through the miR‐520f‐3p/ELK4 axis
Liangqin Nie, Tianyu Jiang
International Journal of Developmental Neuroscience (2024) Vol. 84, Iss. 6, pp. 581-593
Closed Access

An insight into the therapeutic effects of isoliquiritigenin in breast cancer
Divya Sharma, Mahaveer Dhobi, Viney Lather, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9503-9519
Closed Access

Page 1 - Next Page

Scroll to top